切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2022, Vol. 16 ›› Issue (03) : 303 -306. doi: 10.3877/cma.j.issn.1674-3946.2022.03.019

论著

腹腔镜袖状胃切除术治疗肥胖合并2型糖尿病患者的近期疗效
曹新岭1, 吐尔洪江·吐逊1, 姚刚1, 沙地克·阿帕尔1, 曹峻1, 周成明1, 赵晋明1, 李涛1,()   
  1. 1. 830054 乌鲁木齐,新疆医科大学第一附属医院肝脏·腹腔镜外科,省部共建中亚高发病成因与防治国家重点实验室
  • 收稿日期:2021-05-19 出版日期:2022-04-26
  • 通信作者: 李涛

Short-term effects of laparoscopic sleeve gastrectomy in patients with Obesity and Type 2 diabetes mellitus

Xinling Cao1, Turhongjiang Tuxun1, Gang Yao1, Shadike Apaer1, Jun Cao1, Chengming Zhou1, Jinming Zhao1, Tao Li1,()   

  1. 1. Department of Liver & Laparoscopic Surgery,State Key Laboratory of Pathogenesis,Prevention and Treatment of High Incidence Diseases in Central Asia,The First Affiliated Hospital of Xinjiang Medical University,Wulumuqi Xinjiang Uygur Autonomous Region 830054,China
  • Received:2021-05-19 Published:2022-04-26
  • Corresponding author: Tao Li
  • Supported by:
    State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia Fund(SKL-HIDCA-2020-43)
引用本文:

曹新岭, 吐尔洪江·吐逊, 姚刚, 沙地克·阿帕尔, 曹峻, 周成明, 赵晋明, 李涛. 腹腔镜袖状胃切除术治疗肥胖合并2型糖尿病患者的近期疗效[J/OL]. 中华普外科手术学杂志(电子版), 2022, 16(03): 303-306.

Xinling Cao, Turhongjiang Tuxun, Gang Yao, Shadike Apaer, Jun Cao, Chengming Zhou, Jinming Zhao, Tao Li. Short-term effects of laparoscopic sleeve gastrectomy in patients with Obesity and Type 2 diabetes mellitus[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2022, 16(03): 303-306.

目的

探讨腹腔镜袖状胃切除术(LSG)治疗肥胖合并2型糖尿病(T2DM)患者的近期疗效。

方法

回顾性分析2015年6月至2019年3月接受LSG的95例肥胖合并T2DM患者临床资料。患者术后随访至少24个月,观察手术疗效和术后并发症情况。数据处理采用SPSS 22.0统计软件,术后并发症发生率用[n(%)]表示;手术前后体重相关指标、血糖、血脂指标等计量资料用(

xˉ
±s)表示,多组间比较采用单因素方差分析。P<0.05为差异有统计学意义。

结果

LSG后12个月,患者完全缓解率81.1%(77/95),总有效率93.7%(89/95)。术后患者出现胃切缘出血(3例)、胃漏(1例)、胃角狭窄(1例),术后并发症总发生率为5.3%(5/95)。与术前相比,术后3、6、12个月患者身体质量指数(BMI)、腰臀比(WHR)水平均明显下降,且随时间逐步降低,患者术后多余体质量减少率(EWL%)随时间逐步上升(P<0.05);血清糖化血红蛋白(HbA1c)、空腹血糖(FPG)、胰岛素抵抗指数(HOMA-IR)水平均明显降低,且随时间逐步降低(P<0.05);血清总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)水平均明显降低,且随时间逐步降低,而高密度脂蛋白胆固醇(HDL-C)均明显升高,且随时间逐步升高(P<0.05)。

结论

LSG治疗肥胖合并T2DM近期疗效确切,能够有效缓解病情,患者术后并发症较少,减重效果好,且能够有效控制患者糖脂代谢水平。

Objective

To investigate the short-term efficacy of laparoscopic sleeve gastrectomy(LSG)in the treatment of obese patients with type 2 diabetes mellitus(T2DM).

Methods

Clinical data of 95 obese patients with T2DM who underwent LSG from June 2015 to March 2019 were analyzed retrospectively. The patients were followed up for at least 24 months to observe the efficacy and postoperative complications. The data were processed by SPSS 22.0 statistical software,the incidence of postoperative complications was expressed by[n(%)];Before and after operation,weight related indexes,blood glucose index,blood lipid index and other measurement data were expressed by(

xˉ
±s).One-way ANOVA was performed for comparison between multiple groups. P<0.05 was statistically significant.

Results

At 12 months after LSG,the complete remission rate was 81.1%(77/95),and the total response rate was 93.7%(89/95). Postoperative patients had gastric margin bleeding(3 cases),gastric leakage(1 case),gastric Angle stenosis(1 case),and the overall incidence of postoperative complications was 5.3%(5/95). Compared with preoperative,body mass index(BMI)and waist-hip ratio(WHR)levels were significantly decreased at 3,6 and 12 months after surgery,and gradually decreased with time,while the rate of excess body mass loss(EWL%)was gradually increased with time(P<0.05). Serum HbA1c,fasting blood glucose(FPG)and insulin resistance index(HOMA-IR)levels were significantly decreased with time(P<0.05). Serum total cholesterol(TC),triglyceride(TG)and low density lipoprotein cholesterol(LDL-C)levels were significantly decreased,and gradually decreased with time,while high density lipoprotein cholesterol(HDL-C)levels were significantly increased,and gradually increased with time(P<0.05).

Conclusion

LSG has a definite short-term effect in the treatment of obesity complicated with T2DM,which can effectively alleviate the disease,reduce complications,reduce weight,and effectively control the glucose and lipid metabolism level of patients.

表1 95例肥胖合并T2DM患者LSG后体重相关指标改善情况(
xˉ
±s
表2 95例肥胖合并T2DM患者LSG后血糖相关指标的改善情况(
xˉ
±s
表3 95例肥胖合并T2DM患者LSG后血脂相关指标的改善情况[(
xˉ
±s),mmol/L]
[1]
范美球,徐谷根,田慧. 膳食纤维强化饮食干预对早期肥胖型2型糖尿病的疗效分析[J]. 新医学201950(11):845-849.
[2]
郑云芝,林忆阳,徐向进. 超重与肥胖2型糖尿病患者的膳食结构调查分析[J]. 中华糖尿病杂志201911(11):742-746.
[3]
周旭,朱卫丰,陈晓凡,等. 减重手术对超重/肥胖合并2型糖尿病患者糖化血红蛋白影响的网状Meta分析[J]. 中国循证医学杂志202020(9):1059-1068.
[4]
Courcoulas APGallagher JWNeiberg RH,et al. Bariatric Surgery vs Lifestyle Intervention for Diabetes Treatment:5-Year Outcomes From a Randomized Trial[J]. J Clin Endocrinol Metab2020105(3):866-876.
[5]
Yan YWang FChen H,et al. Efficacy of laparoscopic gastric bypass vs laparoscopic sleeve gastrectomy in treating obesity combined with type-2 diabetes[J]. Br J Biomed Sci202178(1):35-40.
[6]
王文越,杨珵璨,王兵. 减重代谢手术治疗重度肥胖合并2型糖尿病术后1年疗效分析[J]. 腹腔镜外科杂志201823(1):12-16.
[7]
朱信强,黄海龙,蒋学通,等. 腹腔镜下袖状胃切除术治疗高体重指数2型糖尿病的效果分析[J/CD]. 中华普外科手术学杂志(电子版)202014(2):132-135.
[8]
Al-Shawaf EAl-Ozairi EAl-Asfar F,et al. Biphasic changes in angiopoietin-like 8 level after laparoscopic sleeve gastrectomy and type 2 diabetes remission during a 1-year follow-up[J]. Surg Obes Relat Dis201814(9):1284-1294.
[9]
中华医学会内分泌学分会. 中国2型糖尿病合并肥胖综合管理专家共识[J]. 中华内分泌代谢杂志201632(8):623-627.
[10]
王芳,王润华,徐开盛,等. 腹腔镜胃旁路术治疗非肥胖2型糖尿病的疗效与安全性分析[J/CD]. 中华普通外科学文献(电子版)201913(5):359-362.
[11]
孙红,查敏,郭雨亭,等. 新诊断2型糖尿病合并超重/肥胖患者肝脏脂肪含量及其影响因素[J]. 中国糖尿病杂志201927(8):582-586.
[12]
Li ZJYu JCKang WM,et al. [Effectiveness of Laparoscopic Sleeve Gastrectomy in Treating Obesity and Its Co-morbidities][J]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao201840(5):610-616.
[13]
Kelly TUnwin DFinucane F. Low-Carbohydrate Diets in the Management of Obesity and Type 2 Diabetes:A Review from Clinicians Using the Approach in Practice[J]. Int J Environ Res Public Health202017(7):2557.
[14]
朱信强,单晓东,马济雷,等. 两种代谢手术治疗肥胖型2型糖尿病的对比分析[J/CD]. 中华普外科手术学杂志(电子版)202014(5):476-479.
[15]
Murphy RClarke MGEvennett NJ,et al. Laparoscopic Sleeve Gastrectomy Versus Banded Roux-en-Y Gastric Bypass for Diabetes and Obesity:a Prospective Randomised Double-Blind Trial[J]. Obes Surg201828(2):293-302.
[16]
孙康,蔡逊. 腹腔镜袖状胃切除术治疗肥胖症合并2型糖尿病的研究与进展[J]. 华南国防医学杂志201933(5):360-363, 封3.
[17]
汪波,杨丽洁,杨张朔,等. 3D腹腔镜Roux-en-Y胃旁路术与袖状胃切除术治疗肥胖症合并2型糖尿病临床疗效的比较[J]. 中华实验外科杂志201936(1):134-137.
[18]
Salminen PHelmio MOvaska J,et al. Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss at 5 Years Among Patients With Morbid Obesity:The SLEEVEPASS Randomized Clinical Trial[J]. JAMA2018319(3):241-254.
[19]
汪波,王丹雯,习一清,等. 3D腹腔镜袖状胃切除术治疗肥胖症合并2型糖尿病的临床疗效及机制[J]. 中华实验外科杂志201835(12):2310-2313.
[20]
Ser KHLee WJChen JC,et al. Laparoscopic single-anastomosis duodenal-jejunal bypass with sleeve gastrectomy(SADJB-SG):Surgical risk and long-term results[J]. Surg Obes Relat Dis201915(2):236-243.
[21]
Hayoz CHermann TRaptis DA,et al. Comparison of metabolic outcomes in patients undergoing laparoscopic roux-en-Y gastric bypass versus sleeve gastrectomy-a systematic review and meta-analysis of randomised controlled trials[J]. Swiss Med Wkly2018148:w14633.
[1] 曹雯佳, 刘学兵, 罗安果, 钟释敏, 邓岚, 王玉琳, 李赵欢. 超声矢量血流成像对2型糖尿病患者颈动脉壁剪切应力的研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(07): 709-717.
[2] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[3] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[4] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[5] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[6] 王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[7] 康婵娟, 张海涛, 翟静洁. 胰管支架置入术治疗急性胆源性胰腺炎的效果及对患者肝功能、炎症因子水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 667-670.
[8] 许月芳, 刘旺, 曾妙甜, 郭宇姝. 多粘菌素B和多粘菌素E治疗外科多重耐药菌感染临床疗效及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 700-703.
[9] 付成旺, 杨大刚, 王榕, 李福堂. 营养与炎症指标在可切除胰腺癌中的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 704-708.
[10] 孟令凯, 李大勇, 王宁, 王桂明, 张炳南, 李若彤, 潘立峰. 袖状胃切除术对肥胖伴2型糖尿病大鼠的作用及机制研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 638-642.
[11] 许杰, 李亚俊, 冯义文. SOX新辅助化疗后腹腔镜胃癌D2根治术与常规根治术治疗进展期胃癌的近期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 647-650.
[12] 玉素江·图荪托合提, 韩琦, 麦麦提艾力·麦麦提明, 黄旭东, 王浩, 克力木·阿不都热依木, 艾克拜尔·艾力. 腹腔镜袖状胃切除或联合食管裂孔疝修补术对肥胖症合并胃食管反流病的中期疗效分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 501-506.
[13] 刘见, 杨晓波, 何均健, 等. 应用电钩三孔法腹腔镜袖状胃切除术[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(06): 363-364.
[14] 王璇, 娜扎开提·尼加提, 雒洋洋, 蒋升. 皮肤晚期糖基化终末产物浓度与2型糖尿病微血管并发症的相关性[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 447-454.
[15] 王星, 陈园, 热孜万古丽·乌斯曼, 郭艳英. T2DM、Obesity、NASH、PCOS共同致病因素相关的分子机制[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 481-490.
阅读次数
全文


摘要